As the pancreatic ductal progenitors normally initiate adenocarcinoma, and mesenchymal progenitors normally initiate sarcomas, the ability to induce tumors morphologically consistent with poorly differentiated SCC-like tumor consistently indicated a strong reprogramming activity of Brd4::Nutm1 (49, 51). This evidence concerns the gene BRD4 and sarcoma.